The relationships between glutamatergic neurometabolites and cortical thickness in patients with treatment-resistant schizophrenia
The relationships between glutamatergic neurometabolites and cortical thickness in patients with treatment-resistant schizophrenia
难治性精神分裂症患者谷氨酸能神经代谢物与皮质厚度的关系
批准号：
386586
负责人：
Shah Parita
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-12-01 至 2018-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Schizophrenia is a severe mental disorder that affects 1% of the global population. A third of patients with schizophrenia fail to respond to conventional antipsychotic medications, and are thus characterized as having treatment-resistant schizophrenia (T
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
